Incepta Pharmaceuticals Ltd.

incepta-pharma-logoIncepta Pharmaceuticals Ltd. is a leading pharmaceutical company in Bangladesh established in the year 1999. The company has a very big manufacturing facility located at Savar, 35 kilometer away from the center of the capital city Dhaka. The company produces various types of dosage forms which include tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, nasal sprays, eye drops, creams, ointments, lotions, gels, prefilled syringes, liquid filled hard gelatin capsules, lyophilized injections, human vaccine etc. Since its inception, Incepta has been launching new and innovative products in order to fulfill unmet demand of the medical community. The focus has been to bring more new technologically advanced molecules to this country.

The company specializes in value added high technology dosage forms like sustained release tablets, quick mouth dissolving tablets, effervescent tablets, barrier coated delayed release tablets, prefilled syringe products, Insulin and Insulin analogue and biological products, among others . It has established a modern research and development laboratory for the development of new, advanced dosage forms for various drugs and devices like poorly soluble drugs, dry powder inhalers, coated pellets, modified release products, taste masked preparation etc.

Incepta has a very competent sales team, which promotes the specialties throughout the country. The company virtually covers every single corner of the rural as well as urban area of Bangladesh. It has its own large distribution network having 18 depots all over the country. The company has a clear vision to become a leading research based dosage form manufacturing company with global presence within a short period of time. With this view in mind the company started to expand its business in overseas markets. Currently Incepta exports to 46 different countries around the world. With hundreds of brands registered in different countries, and many more in the pipeline, Incepta is gradually expanding its global footprint across all the continents.

Company’s state-of-the-Art R&D lab employs sophisticated and advanced technology to bring newer products through research hitherto unknown in this country. Such activities will not only benefit the company but also the total pharmaceutical sector of the country. In the post 2005 era, the company also intends to embark into the production of Active Pharmaceutical Ingredient (API). Plans are underway to get into reverse engineering and analogue research in order to produce new API.

On 15th January 2011, Incepta implemented globally acclaimed ERP software system – SAP. Incepta is the first Bangladeshi company to implement SAP to manage resources throughout the company operation. This world class resource management system will allow the company to become more efficient and effective in its day to day operation.

The company is continuously expanding its activities beyond the geographical boundary of Bangladesh. The company is open to collaborate with interested and relevant parties in various countries Incepta will continue to strive to provide high quality medicine at affordable prices to the people here in Bangladesh and other parts of the globe.

During the course of the last couple of years the company has received accreditation from many other countries of the world and currently holds the following GMP certificates from their respective Ministry of Health.

  • UK MHRA GMP Certificate
  • European Union GMP Certificate
  • Turkey GMP Certificate
  • Yemen GMP Certificate
  • Kenya GMP Certificate
  • Democratic Republic of Congo GMP Certificate
  • Ethiopia GMP Certificate
  • Uganda GMP Certificate

Production Facilities

At present Incepta has one fully operational plant at Zirabo, Savar, Dhaka (Zirabo plant) and another at Dhamrai, Dhaka. The second site is currently under development and several projects of finished formulation unit are being set up.

The Zirabo manufacturing plant is located about 35 Km north of Dhaka City and covers an area of land about 15,000 m2. The total built up production area is about 300,000 square feet. Currently the plant consists of a general purpose manufacturing building, a dedicated cephalosporin manufacturing building, and a specialized manufacturing building for the production of lyophilized products, insulin and amino acids in addition to several floors dedicated to the production of solid dosage forms- tablets and capsules. A newly built liquid and semisolid manufacturing building is also in operation at this site.

The following product forms are manufactured on site:

A. Sterile Products:

  • Liquid dosage forms (LVP & SVP, Terminally sterilized and aseptically filled ampoule)
  • Eye Drops
  • Solid dosage forms (Solid fill, Dry vials and Freeze-Dried Products)

B. Non Sterile Products:

  • Liquid dosage forms (Oral Liquid, Nasal Solution, Nasal Spray)
  • Semisolid dosage forms (Creams, Ointments, Gels)
  • Solid dosage forms (Tablets, Capsules, Powders, Granules)

C. Biological Products:

  • Aseptically prepared injectables: Erythropoetin, Enoxaparin, Insulin, Insulin Glargine (rDNA), Filgrastim

D. Cephalosporins (Dedicated manufacturing facility):

  • Solid dosage forms (Tablets, Capsules, Powder)
  • Sterile Powders (Aseptically filled vials)

40,  Shahid Tajuddin Ahmed Sarani, Tejgaon I/A, Dhaka-1208, Bangladesh.
Phone: (+88 02) 8891688 – 703
Fax: (+88 02) 8891190